Global Implantable Left Ventricular Assist Device Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Implantable Left Ventricular Assist Device Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global Implantable Left Ventricular Assist Device market size was valued at USD 2512.9 million in 2022 and is forecast to a readjusted size of USD 6502 million by 2029 with a CAGR of 14.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

A left ventricular assist device (LVAD) is a pump that use for patients who have reached end-stage heart failure. We surgically implant the LVAD, a battery-operated, mechanical pump, which then helps the left ventricle (main pumping chamber of the heart) pump blood to the rest of the body. The LVAD pulls blood from the left ventricle into a pump. The pump then sends blood into the aorta (the large blood vessel leaving the left ventricle). This helps the weakened ventricle. The pump is placed in the upper part of the abdomen, while another tube attached to the pump is brought out of the abdominal wall to the outside of the body and attached to the pump's battery and control system.LVADs are now portable and can be used for many years. Patients with LVADs can be discharged from the hospital, return to their normal activities and enjoy a good quality of life while waiting for a donor heart to become available. Destination therapy patients, who are not transplant candidates, can also enjoy this same quality of life for years after implantation.

This report is a detailed and comprehensive analysis for global Implantable Left Ventricular Assist Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Implantable Left Ventricular Assist Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Implantable Left Ventricular Assist Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Implantable Left Ventricular Assist Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Implantable Left Ventricular Assist Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Implantable Left Ventricular Assist Device

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Implantable Left Ventricular Assist Device market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Abbott(HeartMate）, SynCardia Systems, Berlin Heart and Johnson&Johnson(Abiomed), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Implantable Left Ventricular Assist Device market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Bridge-To-Transplant Therapy
Destination Therapy

Market segment by Application
Hospital
Specialized Hospital
Other

Major players covered
Medtronic
Abbott(HeartMate）
SynCardia Systems
Berlin Heart
Johnson&Johnson(Abiomed)
Jarvik Heart
ReliantHeart
Evaheart,Inc.
CH Biomedical,Inc.

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Implantable Left Ventricular Assist Device product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Implantable Left Ventricular Assist Device, with price, sales, revenue and global market share of Implantable Left Ventricular Assist Device from 2018 to 2023.

Chapter 3, the Implantable Left Ventricular Assist Device competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Implantable Left Ventricular Assist Device breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Implantable Left Ventricular Assist Device market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Implantable Left Ventricular Assist Device.

Chapter 14 and 15, to describe Implantable Left Ventricular Assist Device sales channel, distributors, customers, research findings and conclusion.